510(k) Report

510(k) · Cleared

Cleared

IL Test Antithrombin

K980499510(k) TraditionalCleared Apr 2, 199852-day reviewClass II21 CFR 864.7060

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Instrumentation Laboratory CO · JBQ Antithrombin Iii Quantitation

Cleared on Apr 2, 1998 as substantially equivalent to K915083 (Kabi Pharmacia, Inc., 1992) after a 52-day review. Its family tree reaches back 1 generation to 1992. 9 later devices descend from it.

Decided
Apr 2, 1998
Review
52 days
Class
Class II
Product code
JBQ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K915083 (1992). 9 later devices descend from it, 4 citing it directly.

Descendants, by year cleared 2007: 1 descendant cleared2000: 1 descendant cleared2002: 2 descendants cleared2004: 1 descendant cleared2003: 1 descendant cleared2006: 1 descendant cleared2005: 1 descendant cleared2018: 1 descendant clearedK915083 · Coamate (R) Antithrombin Chromogenic Assay · Kabi Pharmacia, Inc. · 19921990200020102020
Descendants, by generation 1 generation forward: 4 descendants2 generations forward: 3 descendants3 generations forward: 2 descendants K915083 · Coamate (R) Antithrombin Chromogenic Assay · Kabi Pharmacia, Inc. · 19920
  1. Root · 1 generation backK915083 Coamate (R) Antithrombin Chromogenic AssayKabi Pharmacia, Inc. · 1992
  2. This deviceK980499 IL Test AntithrombinInstrumentation Laboratory CO · 1998
  3. Descendant · cites it directly · 4 of its ownK994238 IL Test Liquid AntithrombinInstrumentation Laboratory CO · 2000
  4. Descendant · cites it directly · 2 of its ownK033775 Hemosil Liquid Antithrombin XLInstrumentation Laboratory CO · 2004
  5. Descendant · cites it directly · 2 of its ownK022195 Coamatic at-400Instrumentation Laboratory CO · 2002
  6. Descendant · 2 generations on · 1 of its ownK062431 Hemosil Liquid AntithrombinInstrumentation Laboratory CO · 2006
  7. Descendant · 2 generations on · 1 of its ownK023991 Chromocheck Antithrombin 25; Chromocheck Antithrombin 50Precision Biologic · 2003

Showing 5 of 9 descendants. See all descendants

Descendants cleared per year

2000: 12002: 22003: 12004: 12005: 12006: 12007: 12018: 1
2000high 2 (2002) · low 0 (2001)2026

Most influential descendants

Showing 5 of 9 · See all
  • K994238IL Test Liquid AntithrombinInstrumentation Laboratory CO · 2000 · cites it directly4descendants
  • K033775Hemosil Liquid Antithrombin XLInstrumentation Laboratory CO · 2004 · cites it directly2descendants
  • K022195Coamatic at-400Instrumentation Laboratory CO · 2002 · cites it directly2descendants
  • K062431Hemosil Liquid AntithrombinInstrumentation Laboratory CO · 2006 · 2 generations on1descendant
  • K023991Chromocheck Antithrombin 25; Chromocheck Antithrombin 50Precision Biologic · 2003 · 2 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K915083Coamate (R) Antithrombin Chromogenic AssayKabi Pharmacia, Inc.1992—
0 (this device)K980499IL Test AntithrombinInstrumentation Laboratory CO1998—
+1K994238IL Test Liquid AntithrombinInstrumentation Laboratory CO2000—
+1K033775Hemosil Liquid Antithrombin XLInstrumentation Laboratory CO2004—
+1K022195Coamatic at-400Instrumentation Laboratory CO2002—
+2K062431Hemosil Liquid AntithrombinInstrumentation Laboratory CO2006—
+2K023991Chromocheck Antithrombin 25; Chromocheck Antithrombin 50Precision Biologic2003—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200010
200220
200310
200410
200510
200610
200710
201810
FIG. 1 — Lineage of K980499, 1992–2018Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JBQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JBQ device

  1. #1 K242952 INNOVANCE Antithrombinscore 9.1 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K915083Coamate (R) Antithrombin Chromogenic Assay
Summary page 1
…ice: IL Test™ Antithrombin Classification name(s): 864.7060 Antithrombin 1II Assay Class I1 81JBQ Antithrombin III Quantitation Identification of predicate device(s): K915083 Coamatic® Antithrombin (originally named Coamate Antithrombin) Description of the device/intended use(s): IL Test™ Antithrombi…
Kabi Pharmacia, Inc.1992—

Also cleared against K915083: 1 other device →

What descends from it? (9)

4 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K994238IL Test Liquid AntithrombinInstrumentation Laboratory CO20004
K033775Hemosil Liquid Antithrombin XLInstrumentation Laboratory CO20042
K022195Coamatic at-400Instrumentation Laboratory CO20022
K070301Hemosil AntithrombinInstrumentation Laboratory CO20070

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K994238 (Instrumentation Laboratory CO, 2000) has gone furthest, with 4 descendants of its own.
  • 1 other device also cites its predicate K915083.

How does its category compare?

All JBQ devices

JBQ Antithrombin Iii Quantitation: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · JBQ

1in 2025

2007: 12009: 12025: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JBQ

Too few JBQ 510(k)s in any year since 2007 to give a median.

Recalls per year · JBQ

No recall names JBQ since 2007.

Adverse event reports per year · JBQ

1in 2023

2013: 12022: 12023: 1
2007high 1 (2013) · low 0 (2007)2025

MAUDE reports naming product code JBQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20100—00
20110—00
20120—00
20130—01
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—01
20230—01
20240—00
20251—00
20260—0—

What is it indicated for?

IL Test™ Antithrombin is an in vitro diagnostic test for the quantitative determination of

Antihrombin in human plasma to monitor the administration of heparin in the treatment of

thrombosis and as an aid in the diagnosis of thrombophilia (a congenital deficiency of

Antithrombin).

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K980499: IL Test Antithrombin.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K980499

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026